{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:16:28Z","timestamp":1777392988778,"version":"3.51.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>\u03b12-Antiplasmin (A2AP) is a major inhibitor of fibrinolysis by virtue of its capacity to inhibit plasmin. Although the fibrinolytic system is strongly affected by infection, the functional role of A2AP in the host response to sepsis is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To study the role of A2AP in melioidosis, a common form of community-acquired sepsis in Southeast Asia and Northern Australia caused by the gram-negative bacterium Burkholderia pseudomallei.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a single-center observational study A2AP was measured in patients with culture-proven septic melioidosis. Wild-type and A2AP-deficient (A2AP\u2212\/\u2212) mice were intranasally infected with B. pseudomallei to induce severe pneumosepsis (melioidosis). Parameters of inflammation and coagulation were measured, and survival studies were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Patients with melioidosis showed elevated A2AP plasma levels. Likewise, A2AP levels in plasma and lung homogenates were elevated in mice infected with B. pseudomallei. A2AP-deficient (A2AP\u2212\/\u2212) mice had a strongly disturbed host response during experimental melioidosis as reflected by enhanced bacterial growth at the primary site of infection accompanied by increased dissemination to distant organs. In addition, A2AP\u2212\/\u2212 mice showed more severe lung pathology and injury together with an increased accumulation of neutrophils and higher cytokine levels in lung tissue. A2AP deficiency further was associated with exaggerated systemic inflammation and coagulation, increased distant organ injury, and enhanced lethality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study is the first to identify A2AP as a protective mediator during gram-negative (pneumo)sepsis by limiting bacterial growth, inflammation, tissue injury, and coagulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201307-1344oc","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T10:56:43Z","timestamp":1377860203000},"page":"967-975","source":"Crossref","is-referenced-by-count":33,"title":["Endogenous \u03b12-Antiplasmin Is Protective during Severe Gram-Negative Sepsis (Melioidosis)"],"prefix":"10.1093","volume":"188","author":[{"given":"Liesbeth M.","family":"Kager","sequence":"first","affiliation":[{"name":"Center of Experimental and Molecular Medicine (CEMM)"},{"name":"Center for Infection and Immunity Amsterdam (CINIMA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassili A.","family":"Weehuizen","sequence":"additional","affiliation":[{"name":"Center of Experimental and Molecular Medicine (CEMM)"},{"name":"Center for Infection and Immunity Amsterdam (CINIMA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Joost","family":"Wiersinga","sequence":"additional","affiliation":[{"name":"Center of Experimental and Molecular Medicine (CEMM)"},{"name":"Center for Infection and Immunity Amsterdam (CINIMA)"},{"name":"Department of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris J. T. H.","family":"Roelofs","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost C. M.","family":"Meijers","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, and"},{"name":"Department of Vascular Medicine, Academic Medical Center\/University of Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; and"},{"name":"Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"van \u2019t Veer","sequence":"additional","affiliation":[{"name":"Center of Experimental and Molecular Medicine (CEMM)"},{"name":"Center for Infection and Immunity Amsterdam (CINIMA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[{"name":"Center of Experimental and Molecular Medicine (CEMM)"},{"name":"Center for Infection and Immunity Amsterdam (CINIMA)"},{"name":"Department of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"2026032100444245200_bib1","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib3","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/00003246-200009001-00017","article-title":"Phylogenetic and functional relationships between coagulation and the innate immune response","volume":"28","author":"Opal","year":"2000","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"2026032100444245200_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2007.02430.x","article-title":"TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots","volume":"5","author":"Mutch","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026032100444245200_bib6","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1111\/j.1742-4658.2005.04881.x","article-title":"Antiplasmin: the forgotten serpin?","volume":"272","author":"Coughlin","year":"2005","journal-title":"FEBS J"},{"key":"2026032100444245200_bib7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-2516.2008.01766.x","article-title":"Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance","volume":"14","author":"Carpenter","year":"2008","journal-title":"Haemophilia"},{"key":"2026032100444245200_bib8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood-2001-12-0251","article-title":"Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction","volume":"100","author":"Matsuno","year":"2002","journal-title":"Blood"},{"key":"2026032100444245200_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/00365518909089079","article-title":"Differences in coagulation and fibrinolysis after traumatic and septic shock in man","volume":"49","author":"Bagge","year":"1989","journal-title":"Scand J Clin Lab Invest"},{"key":"2026032100444245200_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","article-title":"Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease","volume":"57","author":"Brandtzaeg","year":"1990","journal-title":"Thromb Res"},{"key":"2026032100444245200_bib11","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1378\/chest.103.5.1536","article-title":"Time course of hemostatic abnormalities in sepsis and its relation to outcome","volume":"103","author":"Lorente","year":"1993","journal-title":"Chest"},{"key":"2026032100444245200_bib12","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00134-001-1139-8","article-title":"Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock","volume":"27","author":"Mavrommatis","year":"2001","journal-title":"Intensive Care Med"},{"key":"2026032100444245200_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0037-1616084","article-title":"Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients","volume":"86","author":"Raaphorst","year":"2001","journal-title":"Thromb Haemost"},{"key":"2026032100444245200_bib14","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","article-title":"Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study","volume":"31","author":"de Kleijn","year":"2003","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome","volume":"161","author":"Gunther","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100444245200_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-200702000-00012","article-title":"Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa","volume":"106","author":"Song","year":"2007","journal-title":"Anesthesiology"},{"key":"2026032100444245200_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI-1 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res"},{"key":"2026032100444245200_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thorax.2003.013888","article-title":"Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia","volume":"59","author":"Schultz","year":"2004","journal-title":"Thorax"},{"key":"2026032100444245200_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1183\/09031936.04.00140703","article-title":"Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection","volume":"24","author":"Choi","year":"2004","journal-title":"Eur Respir J"},{"key":"2026032100444245200_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2007.07.011","article-title":"Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections","volume":"27","author":"Lim","year":"2007","journal-title":"Immunity"},{"key":"2026032100444245200_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2006-05-025197","article-title":"Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia","volume":"109","author":"Renckens","year":"2007","journal-title":"Blood"},{"key":"2026032100444245200_bib22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1538-7836.2011.04473.x","article-title":"Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis)","volume":"9","author":"Kager","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2026032100444245200_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor-1","volume":"3","author":"Lijnen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026032100444245200_bib24","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","article-title":"The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study","volume":"4","author":"Currie","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2026032100444245200_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"2026032100444245200_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"2026032100444245200_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/490456a","article-title":"Viral research faces clampdown","volume":"490","author":"Butler","year":"2012","journal-title":"Nature"},{"key":"2026032100444245200_bib28","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1097\/CCM.0b013e31824ea05e","article-title":"Endogenous tissue-type plasminogen activator impairs host defense during severe experimental gram-negative sepsis (melioidosis)","volume":"40","author":"Kager","year":"2012","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib29","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1371\/journal.pmed.0040248","article-title":"Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis)","volume":"4","author":"Wiersinga","year":"2007","journal-title":"PLoS Med"},{"key":"2026032100444245200_bib30","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood.V93.7.2274","article-title":"Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding","volume":"93","author":"Lijnen","year":"1999","journal-title":"Blood"},{"key":"2026032100444245200_bib31","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1538-7836.2007.02745.x","article-title":"Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis","volume":"5","author":"Kanno","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026032100444245200_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.shk.0000144422.32647.b6","article-title":"Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers","volume":"23","author":"Iba","year":"2005","journal-title":"Shock"},{"key":"2026032100444245200_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1538-7836.2007.02796.x","article-title":"Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis","volume":"6","author":"Wiersinga","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2026032100444245200_bib34","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/01.CCM.0000057849.53689.65","article-title":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia","volume":"31","author":"Levi","year":"2003","journal-title":"Crit Care Med"},{"key":"2026032100444245200_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2353\/ajpath.2010.090150","article-title":"alpha2-antiplasmin is associated with the progression of fibrosis","volume":"176","author":"Kanno","year":"2010","journal-title":"Am J Pathol"},{"key":"2026032100444245200_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-beta","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J Biochem"},{"key":"2026032100444245200_bib37","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"2026032100444245200_bib38","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/IAI.05534-11","article-title":"Expression and function of transforming growth factor beta in melioidosis","volume":"80","author":"Weehuizen","year":"2012","journal-title":"Infect Immun"},{"key":"2026032100444245200_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/509810","article-title":"A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei","volume":"195","author":"Easton","year":"2007","journal-title":"J Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/8\/967\/67292354\/ajrccm_188_8_967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/8\/967\/67292354\/ajrccm_188_8_967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:46:42Z","timestamp":1774068402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/188\/8\/967\/8506721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,10,15]]},"published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201307-1344oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10]]}}}